David M Cordas Dos Santos

8PUBLICATIONS
60CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 20, 2026
Ciltacabtagene autoleucel in high-risk smoldering multiple myeloma: the CAR-PRISM phase 2 trial.

|Mar 25, 2026
Enhanced dynamic risk stratification of smoldering multiple myeloma.

Floris Chabrun, Daniel E Schwartz, Susanna Gentile

|Jun 12, 2025
Enhanced Risk Stratification of Smoldering Multiple Myeloma with Dynamic Biomarkers: A Multinational, Multicenter Study including 2,270 Participants (PANGEA 2.0).

Floris Chabrun, Daniel Schwartz, Susanna Gentile

|May 21, 2025
Genomic landscape of multiple myeloma and its precursor conditions.

Jean-Baptiste Alberge, Ankit K Dutta, Andrea Poletti

|Oct 16, 2024
New horizons in our understanding of precursor multiple myeloma and early interception.

David M Cordas Dos Santos, Rosa Toenges, Luca Bertamini

|Sep 11, 2024
Second Primary Malignancies after CAR T-Cell Therapy: A Systematic Review and Meta-analysis of 5,517 Lymphoma and Myeloma Patients.

Tobias Tix, Mohammad Alhomoud, Roni Shouval

Pageof 2

Frequent Collaborators

5 joint publications

Irene M Ghobrial

4 joint publications

Jean-Baptiste Alberge

3 joint publications

María-Victoria Mateos

3 joint publications

Meletios Dimopoulos